Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Thomas, Dilip  [Clear All Filters]
Journal Article
Wei T-T, Chandy M, Nishiga M, Zhang A, Kumar KKrishna, Thomas D, Manhas A, Rhee S, Justesen JMarie, Chen IY, et al. Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation. Cell. 2022.
Chen IY, Olshausen J, Thomas D, Lai C, McLaughlin TL, Wu JC. Generation of three induced pluripotent stem cell lines to model and investigate diseases affecting Hispanics. Stem Cell Res. 2022;65:102969.
Thomas D, Manhas A, Sayed N. Harnessing iPSCs to Dissect Causality in Anthracycline-Induced Cardiotoxicity: All That Fits Are Not Hits. JACC CardioOncol. 2024;6(1):51-54.
Thomas D, Cunningham NJ, Shenoy S, Wu JC. Human iPSCs in Cardiovascular Research: Current Approaches in Cardiac Differentiation, Maturation Strategies, and Scalable Production. Cardiovasc Res. 2021.
Sallam K, Thomas D, Gaddam S, Lopez N, Beck A, Beach L, Rogers AJ, Zhang H, Chen IY, Ameen M, et al. Modeling Effects of Immunosuppressive Drugs on Human Hearts Using Induced Pluripotent Stem Cell-Derived Cardiac Organoids and Single-Cell RNA Sequencing. Circulation. 2022;145(17):1367-1369.
Cao X, Thomas D, Whitcomb LA, Wang M, Chatterjee A, Chicco AJ, Weil MM, Wu JC. Modeling ionizing radiation-induced cardiovascular dysfunction with human iPSC-derived engineered heart tissues. J Mol Cell Cardiol. 2024;188:105-107.
Rhee J-W, Yi H, Thomas D, Lam CKeung, Belbachir N, Tian L, Qin X, Malisa J, Lau E, Paik DT, et al. Modeling Secondary Iron Overload Cardiomyopathy with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Cell Rep. 2020;32(2):107886.
Shah PP, Lv W, Rhoades JH, Poleshko A, Abbey D, Caporizzo MA, Linares-Saldana R, Heffler JG, Sayed N, Thomas D, et al. Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes. Cell Stem Cell. 2021.
Fontana G, Srivastava A, Thomas D, Lalor P, Dockery P, Pandit A. A Three-Dimensional Microgel Platform for the Production of Cell Factories Tailored for the Nucleus Pulposus. Bioconjug Chem. 2014.